ABOUT THIS EVENT
Foghorn Therapeutics Inc. (Nasdaq: FHTX) visits the Nasdaq MarketSite in Times Square to ring the opening bell. Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system.
In honor of the occasion, Adrian Gottschalk, President & CEO, rings the Opening Bell.